Table 2 Capsule compliance, quality of life (SF-12) and graded exercise test (GXT) time to exhaustion data of men (A) and women (B) before and following three weeks of supplementation with Ambrotose AO® at a dosage of 4 capsules per day and placebo (cross-over design with a three week washout between conditions).
A | ||||||||
|---|---|---|---|---|---|---|---|---|
Variable | Trained Men Ambrotose AO® Pre | Trained Men Ambrotose AO® Post | Trained Men Placebo Pre | Trained Men Placebo Post | Untrained Men Ambrotose AO® Pre | Untrained Men Ambrotose AO® Post | Untrained Men Placebo Pre | Untrained Men Placebo Post |
% Capsule Compliance† | NA | 91.9 ± 5.5 | NA | 98.6 ± 1.1 | NA | 88.6 ± 5.5 | NA | 89.8 ± 7.0 |
Physical Health† | 55.4 ± 2.5 | 56.7 ± 1.1 | 57.9 ± 1.2 | 56.9 ± 0.8 | 51.2 ± 4.6 | 48.4 ± 3.5 | 54.0 ± 1.2 | 55.0 ± 1.6 |
Mental Health** | 55.3 ± 1.7 | 54.7 ± 2.3 | 55.1 ± 2.7 | 55.1 ± 1.9 | 48.5 ± 6.5 | 52.4 ± 5.3 | 49.2 ± 3.8 | 49.4 ± 3.6 |
Exercise Time (sec)†* | NA | 1252 ± 45 | NA | 1275 ± 47 | NA | 956 ± 65 | NA | 989 ± 88 |
B | ||||||||
Variable | Trained Women Ambrotose AO ® Pre | Trained Women Ambrotose AO ® Post | Trained Women Placebo Pre | Trained Women Placebo Post | Untrained Women Ambrotose AO ® Pre | Untrained Women Ambrotose AO ® Post | Untrained Women Placebo Pre | Untrained Women Placebo Post |
% Capsule Compliance† | NA | 96.3 ± 1.3 | NA | 93.2 ± 2.6 | NA | 82.5 ± 8.7 | NA | 89.8 ± 5.5 |
Physical Health† | 56.6 ± 1.0 | 55.3 ± 1.8 | 57.9 ± 1.7 | 56.3 ± 2.3 | 54.7 ± 1.3 | 54.7 ± 2.1 | 54.2 ± 2.4 | 53.7 ± 1.6 |
Mental Health** | 50.3 ± 2.6 | 49.9 ± 2.5 | 49.7 ± 3.0 | 51.6 ± 3.0 | 54.0 ± 2.2 | 53.2 ± 3.8 | 51.4 ± 2.1 | 53.7 ± 1.5 |
Exercise Time (sec)†* | NA | 1062 ± 59 | NA | 1064 ± 66 | NA | 839 ± 80 | NA | 853 ± 76 |